.avif)
Intra-cellular Therapies Email Format
Pharmaceutical Manufacturing
・
1,001-2,500 employees
・
Bedminster, NJ, USA
Intra-Cellular Therapies is a biopharmaceutical company developing innovative treatments for complex psychiatric and neurologic diseases using Nobel prize-winning intracellular research.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@itci-inc.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
2002
Headquarters
Bedminster, NJ, USA
Revenue
$500M-$1B
FUNDING Stage
Public
Key Executives
Sharon Mates (Chairman, Chief Executive Officer), Sanjeev Narula (Executive Vice President, Chief Financial Officer), Mark Neumann (Executive Vice President, Chief Commercial Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Intra-cellular Therapies?
Intra-cellular Therapies uses the firstinitiallast format, so Jane Smith would be jsmith@itci-inc.com.
What is Intra-cellular Therapies' approved product CAPLYTA used to treat?
CAPLYTA (lumateperone) is a once-daily oral therapy approved for adults with schizophrenia, depressive episodes associated with bipolar I or II disorder, and as an adjunctive treatment for major depressive disorder.
How did the Johnson and Johnson acquisition change Intra-cellular Therapies' structure?
Johnson and Johnson completed its acquisition of Intra-cellular Therapies in April 2025, after which the company began operating as a business unit within Johnson and Johnson Innovative Medicine.
Where is Intra-cellular Therapies headquartered and how many employees does it have?
Intra-cellular Therapies is headquartered in Bedminster, NJ, and has approximately 698 employees.
What is Intra-cellular Therapies' pipeline compound ITI-1284 being studied for?
ITI-1284 is a Phase 2 compound in clinical development for generalized anxiety disorder and Alzheimer's disease-related psychosis and agitation, representing a key part of Intra-cellular Therapies' neuropsychiatric pipeline.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating